Evidence map›Paper›PMID 39674185›Full record

ArticleLancet (London, England)2025

Regional action needed to halt antimalarial drug resistance in Africa.

Rosario Martinez-Vega, Deus S Ishengoma, Roly Gosling, Philip J Rosenthal, Arjen Dondorp, Karen I Barnes, Christian Nsanzabana, Abdoulaye A Djimde, Lynette I Ochola-Oyier, James Tibenderana and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lancet (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Humanization of Drug Metabolism in theACS infectious diseases · 2025
    Article
  7. A recombinant expression system for thebioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Malaria: past, present, and future.Signal transduction and targeted therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rosario Martinez-VegaDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Deus S IshengomaNational Institute for Medical Research, Dar es Salaam, Tanzania; Department of Biochemistry, Kampala International University in Tanzania, Dar es Salaam, Tanzania.
Roly GoslingDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Malaria Elimination Initiative, Institute of Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
Philip J RosenthalDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Arjen DondorpMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok 10400, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Karen I BarnesDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Christian NsanzabanaSwiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
Abdoulaye A DjimdeMalaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali; Pathogens genomic Diversity Network Africa, Imm Gwancoura, Sotuba, Bamako, Mali.
Lynette I Ochola-OyierCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust, Kenya.
James TibenderanaMalaria Consortium, London, UK.
John ChimumbwaSADC Malaria Elimination 8, Windhoek Namibia.
Lemu GolassaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Ntuli A KapologweDepartment of Preventive Health Services, Ministry of Health, Dodoma, Tanzania.
Wilfred F MbachamThe Fobang Institutes for Innovations in Science & Technology, Yaounde, and the Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon.
Moses R KamyaMakerere University, Kampala, Uganda and Infectious Diseases Research Collaboration, Kampala, Uganda.
David A FidockDepartment of Microbiology and Immunology Columbia University Irving Medical Center, New York, and Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Ryuichi KomatsuNavigo Partners, LLC, Japan; Interfaculty Initiative in Planetary Health and School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Lorenz von SeidleinMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok 10400, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mehul DhordaMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok 10400, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; WorldWide Antimalarial Resistance Network, Oxford, UK. Electronic address: mehul@tropmedres.ac.

Funding

Defining P. falciparum resistance to artemisinin-based combination therapiesR01AI109023 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIDOCK, DAVID A · 2014 to 2025
$4.4M
Defining the complex genetic basis of Plasmodium falciparum resistance to artemisinin and quinine and identifying resistance-refractory therapeuticsR01AI185559 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David A Fidock · 2024 to 2026
$1.9M
NIAID NIH HHS R01 AI109023NIAID NIH HHS R01 AI185559
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39674185
PMCPMC11838165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.